Skip to main content
. 2019 Dec 25;8(4):149–154. doi: 10.14740/jh592

Table 3. Treatment.

Type of treatment No. of patients
Corticosteroids alone 15
Corticosteroids along with chemotherapy (n = 18)
  Dexamethasone and etoposide 6
  Cyclophosphamide, doxorubicin, vincristine and prednisone 2
  Rituximab, etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin and intrathecal methotrexate 2
  Dexamethasone, vincristine and dasatinib 1
  Methylprednisolone, rituximab, etoposide and intravenous immunoglobulin 1
  Methylprednisolone, methotrexate and tocilizumab 1
  Methylprednisolone and rituximab 1
  Methylprednisolone, tumor necrosis factor alpha inhibitor, cyclosporine, anakinra, tocilizumab 1
  Methylprednisolone and cyclosporine 1
  Cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone 1
  Dexamethasone, rituximab, doxorubicin, vinblastine, dacarbazine 1
  Cisplatin, etoposide, gemcitabine, methylprednisolone 1
  Anakinra and prednisone 1
  Etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin for one cycle, then brentuximab 1
Corticosteroids along with antiviral 3
Cytotoxic chemotherapy alone 2
  Azacitidine 1
  Cladribine and cytarabine 1
Intravenous immunoglobulin alone 1
No treatment 2